Margarida Serra’s team from the Instituto de Biologia Experimental e Tecnológica has potentially improved the development of liver disease treatments by controlling the oxygen levels in bioreactors to produce more hepatocyte-like cells (HLCs). Current methods generate low numbers of HLCs, but the research found that reducing oxygen levels to 4% boosts number and differentiation of HLCs, setting the stage for future liver disease treatments.
Journalists Dig Into HHS’ Covid Injury List, ACA Sign-Ups, and Telehealth
Céline Gounder, KFF Health News’ editor-at-large for public health, discussed the Department of Health and Human Services’ plan to offer compensation for automatic covid vaccine
